| Financial Year |
March 31 2023 |
| Monetary Funds |
65,820,861.03 |
| Held-for-trading Financial Assets |
49,000,000.00 |
| Notes Receivable |
53,450,493.58 |
| Accounts Receivable |
556,315,835.55 |
| Advances to Suppliers |
10,097,484.29 |
| Other Receivables |
45,347,753.27 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
283,759,011.65 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,129,879.83 |
| Total Current Assets |
1,167,900,270.59 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
32,402,873.04 |
| Investment Properties |
37,593.97 |
| Fixed Assetes |
150,933,656.91 |
| Under-construction Projects |
110,840,528.99 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
27,064,984.84 |
| R&D expenses |
-- |
| Goodwill |
27,856,283.31 |
| Long-Term Deferred and Prepaid Expenses |
2,119,127.37 |
| Deferred Income Tax Assets |
19,691,288.53 |
| Other Non-Current Assets |
22,429,514.05 |
| Sub-Total of Non-Current Assets |
409,677,445.15 |
| Total Assets |
1,577,577,715.74 |
| Short-Term Loans |
37,800,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
60,234,161.50 |
| Accounts Payable |
331,227,135.67 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
19,680,480.88 |
| Taxes Payable |
25,208,546.65 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
15,568,120.71 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,350,829.18 |
| Other Current Liabilities |
13,713,132.50 |
| Sub-Total of Current Liabilities |
505,917,012.65 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,527,444.81 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
21,769,131.66 |
| Total Liabilities |
527,686,144.31 |
| Paid-In Capital(Or Share Stock) |
223,215,790.00 |
| Capital Surplus |
356,163,561.78 |
| Surplus Reserve |
37,664,972.66 |
| LESS:Treasury Stock |
3,498,064.38 |
| Undistributed Profits |
371,137,671.68 |
| Minority Stockholder's Interest |
65,207,639.69 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
984,683,931.74 |
| Owner's Equity（Stockholder's Equity） |
1,049,891,571.43 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,577,577,715.74 |
